Drug - Synercid
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Dalfopristin; Quinupristin
Multiple ingredients are in alphabetical order.

Strength - 420MG/VIAL;180MG/VIAL
The potency of the active ingredient(s), Dalfopristin; Quinupristin. May repeat for multiple part products.

Applicant - KING PHARMS
The firm name holding legal responsibility for Synercid. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 050748
The FDA assigned number to Synercid. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Synercid. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 24, 2000
The date Synercid was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Synercid. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Synercid is in. Format is RX, OTC, DISCN.

Applicant Full Name - King Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Synercid.